You are here

News

Press Releases

Press Release | August 8, 2018

Washington, D.C. – AdvaMedDx applauds Capitol Hill's release of technical assistance (TA) developed by the Food and Drug Administration (FDA) to draft legislation authored by Representatives Larry Bucshon (R-IN) and Diana DeGette (D-CO) as a significant, positive step toward enacting legislation modernizing regulation of all diagnostics, including Laboratory Developed Tests (LDTs).

Press Release | May 10, 2018

Washington, D.C. – Leading health care companies and organizations representing patients, providers, laboratories and diagnostic manufacturers called on Senate and House leaders to advance legislation that would reform and modernize the process for bringing innovative diagnostics and clinical laboratory tests to market. In a letter to the Chairmen and Ranking members of the Senate Committee on Health, Education, Labor & Pensions (HELP) and House Energy and Commerce Committee, more than 80 organizations urged Congress to prioritize meaningful diagnostic oversight reform in 2018, including for laboratory developed tests (LDTs) and in vitro diagnostics (IVDs).

Press Release | March 21, 2018

WASHINGTON, D.C. - AdvaMedDx, a division of the Advanced Medical Technology Association (AdvaMed) that focuses on the value diagnostics bring to patients' health and health care, while addressing the need for regulatory modernization of the innovative companies that develop and manufacture diagnostic tests, has elected Doug Bryant, president and CEO of Quidel Corporation, as its new Board chair.